SEARCH

SEARCH BY CITATION

References

  • 1
    Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 24958.
  • 2
    Stuehr DJ, Griffith OW. Mammalian nitric oxide synthases. Adv Enzymol Relat Areas Mol Biol 1992; 65: 287346.
  • 3
    Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994; 266: E82939.
  • 4
    Wink DA, Mitchell JB. Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide. Free Radic Biol Med 1998; 25: 43456.
  • 5
    Wink DA, Cook JA, Kim SY et al. Superoxide modulates the oxidation and nitrosation of thiols by nitric oxide-derived reactive intermediates. Chemical aspects involved in the balance between oxidative and nitrosative stress. J Biol Chem 1997; 272: 1114751.
  • 6
    Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991; 43: 10942.
  • 7
    Rubbo H, Radi R, Trujillo M et al. Nitric oxide regulation of superoxide and peroxynitrite-dependent lipid peroxidation. Formation of novel nitrogen-containing oxidized lipid derivatives. J Biol Chem 1994; 269: 2606675.
  • 8
    Grisham MB, Jourd'Heuil D, Wink DA. Nitric oxide – I. Physiological chemistry of nitric oxide and its metabolites: implications in inflammation. Am J Physiol Gastrointest Liver Physiol 1999; 39: G31521.
  • 9
    Tamir S, Tannenbaum SR. The role of nitric oxide (NO) in the carcinogenic process. Biochim Biophys Acta 1996; 1288: F316.
  • 10
    Stamler JS, Jia L, Eu JP et al. Blood flow regulation by S-nitrosohemoglobin in the physiological oxygen gradient. Science 1997; 276: 20347.
  • 11
    Lander HM, Milbank AJ, Tauras JM et al. Redox regulation of cell signalling. Nature 1996; 381: 3801.
  • 12
    Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and the ugly. Am J Physiol 1996; 271: C1424C1437.
  • 13
    Kubes P, Reinhardt PH, Payne D, Woodman RC. Excess nitric oxide does not cause cellular, vascular, or mucosal dysfunction in the cat small intestine. Am J Physiol 1995; 269: G3441.
  • 14
    Moncada S. The 1991 Ulf von Euler Lecture. The l-arginine : nitric oxide pathway. Acta Physiol Scand 1992; 145: 20127.
  • 15
    Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and disfunction. Am J Physiol 1996; 33: G22537.
  • 16
    Kubes P. Nitric oxide modulates epithelial permeability in the feline small intestine. Am J Physiol 1992; 262: G113842.
  • 17
    Kanwar S, Wallace JL, Befus D, Kubes P. Nitric oxide synthesis inhibition increases epithelial permeability via mast cells. Am J Physiol 1994; 266: G2229.
  • 18
    Brown JF, Keates AC, Hanson PJ, Whittle BJ. Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am J Physiol 1993; 265: G41822.
  • 19
    Wilson KT, Vaandrager AB, De Vente J, Musch MW, De Jonge HR, Chang EB. Production and localization of cGMP and PGE2 in nitroprusside-stimulated rat colonic ion transport. Am J Physiol 1996; 270: C83240.
  • 20
    Banick PD, Chen Q, Xu YA, Thom SR. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis. J Cell Physiol 1997; 172: 1224.
  • 21
    Davenpeck KL, Gauthier TW, Lefer AM. Inhibition of endothelial-derived nitric oxide promotes P-selectin expression and actions in the rat microcirculation. Gastroenterology 1994; 107: 10508.
  • 22
    Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA. Effects of reactive oxygen and nitrogen metabolites on MCP-1-induced monocyte chemotactic activity in vitro. Am J Physiol 1999; 277: L5439.
  • 23
    Sato E, Simpson KL, Grisham MB, Koyama S, Robbins RA. Reactive nitrogen and oxygen species attenuate interleukin-8-induced neutrophil chemotactic activity in vitro. J Biol Chem 2000; 275: 1082630.
  • 24
    Radomski MW, Palmer RM, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2: 10578.
  • 25
    Huang FP, Niedbala W, Wei XQ et al. Nitric oxide regulates Th1 cell development through the inhibition of IL-12 synthesis by macrophages. Eur J Immunol 1998; 28: 406270.
  • 26
    Forstermann U, Closs EI, Pollock JS et al. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension 1994; 23: 112131.
  • 27
    Kurose I, Ebinuma H, Higuchi H et al. Nitric oxide mediates mitochondrial dysfunction in hepatoma cells induced by non-activated Kupffer cells: evidence implicating ICAM-1-dependent process. J Gastroenterol Hepatol 1995; 10 (Suppl. 1):S6871.
  • 28
    Tepperman BL, Brown JF, Whittle BJ. Nitric oxide synthase induction and intestinal epithelial cell viability in rats. Am J Physiol 1993; 265: G214G218.
  • 29
    Fukuo K, Inoue T, Morimoto S et al. Nitric oxide mediates cytotoxicity and basic fibroblast growth factor release in cultured vascular smooth muscle cells. A possible mechanism of neovascularization in atherosclerotic plaques. J Clin Invest 1995; 95: 66976.
  • 30
    Fang FC. Perspectives series: host/pathogen interactions. Mechanisms of nitric oxide-related antimicrobial activity. J Clin Invest 1997; 99: 281825.
  • 31
    Witthoft T, Eckmann L, Kim JM, Kagnoff MF. Enteroinvasive bacteria directly activate expression of iNOS and NO production in human colon epithelial cells. Am J Physiol 1998; 275: G56471.
  • 32
    Kolios G, Rooney N, Murphy CT, Robertson DAF, Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T-lymphocyte derived cytokines. Gut 1998; 43: 5663.
  • 33
    Boughton-Smith NK. Pathological and therapeutic implications for nitric oxide in inflammatory bowel disease. J R Soc Med 1994; 87: 3124.
  • 34
    Middleton SJ, Shorthouse M, Hunter JO. Increased nitric oxide synthesis in ulcerative colitis. Lancet 1993; 341: 4656.
  • 35
    Boughton-Smith NK, Evans SM, Hawkey CJ et al. Nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Lancet 1993; 342: 33840.
  • 36
    Lundberg JO, Hellstrom PM, Lundberg JM, Alving K. Greatly increased luminal nitric oxide in ulcerative colitis. Lancet 1994; 344: 16734.
  • 37
    Kolios G, Brown Z, Robson RL, Robertson DAF, Westwick J. Inducible nitric oxide synthase activity and expression in a human colonic epithelial cell line, HT-29. Br J Pharmacol 1995; 116: 286672.
  • 38
    Singer II, Kawka DW, Scott S et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonic epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 87185.
  • 39
    Godkin AJ, De Belder AJ, Villa L et al. Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest 1996; 26: 86772.
  • 40
    Wright KL, Ward SG, Kolios G, Westwick J. Activation of phosphatidylinositol 3-kinase by interleukin-13. An inhibitory signal for inducible nitric-oxide synthase expression in epithelial cell line HT-29. J Biol Chem 1997; 272: 1262633.
  • 41
    Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 5339.
  • 42
    Kolios G, Petoumenos C, Nakos A. Mediators of inflammation: production and implication in inflammatory bowel disease. Hepatogastroenterology 1998; 45: 16019.
  • 43
    Kolios G, Wright KL, Linehan JD, Robertson DA, Westwick J. Interleukin-13 inhibits nitric oxide production in human colonic mucosa. Hepatogastroenterology 2000; 47: 7147.
  • 44
    Kubes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 1993; 264: G1439.
  • 45
    Hutcheson IR, Whittle BJ, Boughton-Smith NK. Role of nitric oxide in maintaining vascular integrity in endotoxin-induced acute intestinal damage in the rat. Br J Pharmacol 1990; 101: 81520.
  • 46
    Peng HB, Libby P, Liao JK. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B. J Biol Chem 1995; 270: 142149.
  • 47
    MacNaughton WK, Cirino G, Wallace JL. Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach. Life Sci 1989; 45: 186976.
  • 48
    Payne D, Kubes P. Nitric oxide donors reduce the rise in reperfusion-induced intestinal mucosal permeability. Am J Physiol 1993; 265: G18995.
  • 49
    Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90: 111621.
  • 50
    Ribbons KA, Zhang X-J, Thompson JH et al. Potential role of nitric oxide in a model of chronic colitis in rhesus macaques. Gastroenterology 1995; 108: 70511.
  • 51
    Middleton SJ, Shorthouse M, Hunter JO. Relaxation of distal colonic circular smooth muscle by nitric oxide derived from human leukocytes. Gut 1993; 34: 8147.
  • 52
    Ohshima H, Bartsch H. Chronic infections and inflammatory processes as cancer risk factors: possible role of nitric oxide in carcinogenesis. Mutat Res 1994; 305: 25364.
  • 53
    Kennedy M, Denenberg AG, Szabo C, Salzman AL. Poly (ADP-ribose) synthetase activation mediates increased permeability induced by peroxynitrite in Caco-2BBe cells. Gastroenterology 1998; 114: 5108.
  • 54
    Sandoval M, Ronzio RA, Muanza DN, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in epithelial (T84) and macrophage (RAW 264.7) cell lines: effect of legume-derived polyphenols (phytolens). Nitric Oxide 1997; 1: 47683.
  • 55
    Kubes P, McCafferty DM. Nitric oxide and intestinal inflammation. Am J Med 2000; 109: 1508.
  • 56
    Rachmilewitz D, Stamler JS, Karmeli F et al. Peroxynitrite-induced rat colitis: a new model of colonic inflammation. Gastroenterology 1993; 105: 16818.
  • 57
    Sandoval M, Liu X, Mannick EE, Clark DA, Miller MJ. Peroxynitrite-induced apoptosis in human intestinal epithelial cells is attenuated by mesalamine. Gastroenterology 1997; 113: 14808.
  • 58
    Mourelle M, Casellas F, Guarner F et al. Induction of nitric oxide synthase in colonic smooth muscle from patients with toxic megacolon. Gastroenterology 1995; 109: 1497502.
  • 59
    Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36: 71823.
  • 60
    Miller MJ, Sadowska-Krowicka H, Chotinaruemol S, Kakkis JL, Clark DA. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993; 264: 116.
  • 61
    Hogaboam CM, Jacobson K, Collins SM, Blennerhassett MG. The selective beneficial effects of nitric oxide inhibition in experimental colitis. Am J Physiol 1995; 268: G673G684.
  • 62
    Rachmilewitz D, Karmeli F, Okon E, Bursztyn M. Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity. Gut 1995; 37: 24755.
  • 63
    Kiss J, Lamarque D, Delchier JC, Whittle BJ. Time-dependent actions of nitric oxide synthase inhibition on colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Eur J Pharmacol 1997; 336: 21924.
  • 64
    Armstrong AM, Campbell GR, Gannon C, Kirk SJ, Gardiner KR. Oral administration of inducible nitric oxide synthase inhibitors reduces nitric oxide synthesis but has no effect on the severity of experimental colitis. Scand J Gastroenterol 2000; 35: 8328.
  • 65
    Yoshida Y, Iwai A, Itoh K et al. Role of inducible nitric oxide synthase in dextran sulphate sodium-induced colitis. Aliment Pharmacol Ther 2000; 14 (Suppl. 1):2632.
  • 66
    Hosoi T, Goto H, Arisawa T et al. Role of nitric oxide synthase inhibitor in experimental colitis induced by 2,4,6-trinitrobenzene sulphonic acid in rats. Clin Exp Pharmacol Physiol 2001; 28: 912.
  • 67
    Yamaguchi T, Yoshida N, Ichiishi E, Sugimoto N, Naito Y, Yoshikawa T. Differing effects of two nitric oxide synthase inhibitors on experimental colitis. Hepatogastroenterology 2001; 48: 11822.
  • 68
    Zingarelli B, Cuzzocrea S, Szabo C, Salzman AL. Mercaptoethylguanidine, a combined inhibitor of nitric oxide synthase and peroxynitrite scavenger, reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 1998; 287: 104855.
  • 69
    Nakamura H, Tsukada H, Oya M et al. Aminoguanidine has both an anti-inflammatory effect on experimental colitis and a proliferative effect on colonic mucosal cells. Scand J Gastroenterol 1999; 34: 111722.
  • 70
    Obermeier F, Kojouharoff G, Hans W, Scholmerich J, Gross V, Falk W. Interferon-gamma (IFN-gamma)- and tumour necrosis factor (TNF)-induced nitric oxide as toxic effector molecule in chronic dextran sulphate sodium (DSS)-induced colitis in mice. Clin Exp Immunol 1999; 116: 23845.
  • 71
    Kankuri E, Vaali K, Knowles RG et al. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl) benzyl]acetamidine. J Pharmacol Exp Ther 2001; 298: 112832.
  • 72
    Menchen LA, Colon AL, Moro MA et al. N-(3-(aminomethyl)benzyl) acetamidine, an inducible nitric oxide synthase inhibitor, decreases colonic inflammation induced by trinitrobenzene sulphonic acid in rats. Life Sci 2001; 69: 47991.
  • 73
    Krieglstein CF, Cerwinka WH, Laroux FS et al. Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001; 194: 120718.
  • 74
    Miller MJS, Thompson JH, Zhang X-J et al. Role of inducible nitric oxide synthase expression and peroxynatrite formation in guinea pig ileitis. Gastroenterology 1995; 109: 147583.
  • 75
    Kankuri E, Asmawi MZ, Korpela R, Vapaatalo H, Moilanen E. Induction of iNOS in a rat model of acute colitis. Inflammation 1999; 23: 14152.
  • 76
    Salas A, Gironella M, Salas A et al. Nitric oxide supplementation ameliorates dextran sulfate sodium-induced colitis in mice. Lab Invest 2002; 82: 597607.
  • 77
    Fiorucci S, Antonelli E, Distrutti E et al. NCX-1015a nitric-oxide derivative of prednisolone, enhances regulatory T cells in the lamina propria and protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis in mice. Proc Natl Acad Sci USA 2002; 99: 157705.
  • 78
    Laszlo F, Whittle BJ, Moncada S. Time-dependent enhancement or inhibition of endotoxin-induced vascular injury in rat intestine by nitric oxide synthase inhibitors. Br J Pharmacol 1994; 111: 130915.
  • 79
    Laszlo F, Evans SM, Whittle BJ. Aminoguanidine inhibits both constitutive and inducible nitric oxide synthase isoforms in rat intestinal microvasculature in vivo. Eur J Pharmacol 1995; 272: 16975.
  • 80
    Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001; 357: 593615.
  • 81
    Szabo C, Ferrer-Sueta G, Zingarelli B, Southan GJ, Salzman AL, Radi R. Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. J Biol Chem 1997; 272: 90306.
  • 82
    Yamada Y, Marshall S, Specian RD, Grisham MB. A comparative analysis of two models of colitis in rats. Gastroenterology 1992; 102: 152434.
  • 83
    Garvey EP, Oplinger JA, Furfine ES et al. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J Biol Chem 1997; 272: 495963.
  • 84
    Zingarelli B, Szabo C, Salzman AL. Reduced oxidative and nitrosative damage in murine experimental colitis in the absence of inducible nitric oxide synthase. Gut 1999; 45: 199209.
  • 85
    McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology 1997; 112: 10227.
  • 86
    McCafferty DM, Miampamba M, Sihota E, Sharkey KA, Kubes P. Role of inducible nitric oxide synthase in trinitrobenzene sulphonic acid induced colitis in mice. Gut 1999; 45: 86473.
  • 87
    McCafferty DM, Sihota E, Muscara M, Wallace JL, Sharkey KA, Kubes P. Spontaneously developing chronic colitis in IL-10/iNOS double-deficient mice. Am J Physiol Gastrointest Liver Physiol 2000; 279: G90G99.
  • 88
    Hokari R, Kato S, Matsuzaki K et al. Reduced sensitivity of inducible nitric oxide synthase-deficient mice to chronic colitis. Free Radic Biol Med 2001; 31: 15363.
  • 89
    Beck PL, Xavier R, Wong J et al. Paradoxical roles of different nitric oxide synthase isoforms in colonic injury. Am J Physiol Gastrointest Liver Physiol 2004; 286: G13747.
  • 90
    Sasaki M, Bharwani S, Jordan P et al. Increased disease activity in eNOS-deficient mice in experimental colitis. Free Radic Biol Med 2003; 35: 167987.
  • 91
    Vallance BA, Dijkstra G, Qiu B et al. Relative contributions of nitric oxide synthase (NOS) isoforms during experimental colitis: endothelial derived NOS maintains mucosal integrity. Am J Physiol Gastrointest Liver Physiol 2004; 287: 686579.
  • 92
    Miampamba M, Sharkey KA. Temporal distribution of neuronal and inducible nitric oxide synthase and nitrotyrosine during colitis in rats. Neurogastroenterol Motil 1999; 11: 193206.
  • 93
    Seifter E, Rettura G, Barbul A, Levenson SM. Arginine: an essential amino acid for injured rats. Surgery 1978; 84: 22430.
  • 94
    Ma L, Wallace JL. Endothelial nitric oxide synthase modulates gastric ulcer healing in rats. Am J Physiol Gastrointest Liver Physiol 2000; 279: G341G346.
  • 95
    Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J. Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol 1993; 239: 2157.
  • 96
    Elliott SN, McKnight W, Cirino G, Wallace JL. A nitric oxide-releasing nonsteroidal anti-inflammatory drug accelerates gastric ulcer healing in rats. Gastroenterology 1995; 109: 52430.
  • 97
    Shi HP, Efron DT, Most D, Tantry US, Barbul A. Supplemental dietary arginine enhances wound healing in normal but not inducible nitric oxide synthase knockout mice. Surgery 2000; 128: 3748.
  • 98
    Yamasaki K, Edington HD, McClosky C et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. J Clin Invest 1998; 101: 96771.
  • 99
    Lee PC, Salyapongse AN, Bragdon GA et al. Impaired wound healing and angiogenesis in eNOS-deficient mice. Am J Physiol 1999; 277: H1600H1608.
  • 100
    Villarete LH, Remick DG. Nitric oxide regulation of IL-8 expression in human endothelial cells. Biochem Biophys Res Commun 1995; 211: 6716.
  • 101
    Vodovotz Y, Chesler L, Chong HY et al. Regulation of transforming growth factor beta 1 by nitric oxide. Cancer Res 1999; 59: 21429.
  • 102
    Witte MB, Thornton FJ, Efron DT, Barbul A. Enhancement of fibroblast collagen synthesis by nitric oxide. Nitric Oxide 2000; 4: 57282.
  • 103
    Ziche M, Morbidelli L, Masini E, Granger H, Geppetti P, Ledda F. Nitric oxide promotes DNA synthesis and cyclic GMP formation in endothelial cells from postcapillary venules. Biochem Biophys Res Commun 1993; 192: 1198203.
  • 104
    Xiong M, Elson G, Legarda D, Leibovich SJ. Production of vascular endothelial growth factor by murine macrophages: regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway. Am J Pathol 1998; 153: 58798.
  • 105
    Alican I, Kubes P. A critical role for nitric oxide in intestinal barrier function and dysfunction. Am J Physiol 1996; 270: G22537.
  • 106
    Grisham MB, Pavlick KP, Laroux FS, Hoffman J, Bharwani S, Wolf RE. Nitric oxide and chronic gut inflammation: controversies in inflammatory bowel disease. J Invest Med 2002; 50: 27283.
  • 107
    Poon BY, Raharjo E, Patel KD, Tavener S, Kubes P. Complexity of inducible nitric oxide synthase: cellular source determines benefit versus toxicity. Circulation 2003; 108: 110712.
  • 108
    Shibata Y, Taruishi M, Ashida T. Experimental ileitis in dogs and colitis in rats with trinitrobenzene sulfonic acid – colonoscopic and histopathologic studies. Gastroenterol Jpn 1993; 28: 51827.
  • 109
    Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694702.
  • 110
    Dieleman LA, Palmen MJ, Akol H et al. Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines. Clin Exp Immunol 1998; 114: 38591.
  • 111
    Kim HS, Berstad A. Experimental colitis in animal models. Scand J Gastroenterol 1992; 27: 52937.
  • 112
    Sundberg JP, Elson CO, Bedigian H, Birkenmeier EH. Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice. Gastroenterology 1994; 107: 172635.
  • 113
    Matsumoto S, Okabe Y, Setoyama H et al. Inflammatory bowel disease-like enteritis and caecitis in a senescence accelerated mouse P1/Yit strain. Gut 1998; 43: 718.
  • 114
    Pizarro TT, Arseneau KO, Bamias G, Cominelli F. Mouse models for the study of Crohn's disease. Trends Mol Med 2003; 9: 21822.